Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alzinova AB | 10,563,722 | net | 08 Apr 2026 | tx 7+10,563,722 |
| Oasmia Pharmaceutical AB | 903,393 | net | 05 Nov 2018 | tx 5+940,144−36,751 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Apr 2026 | PURCHASE | Alzinova AB | 937,500 | 0.10 SEK | deriv |
| 08 Apr 2026 | PURCHASE | Alzinova AB | 937,500 | 0.70 SEK | |
| 13 Mar 2026 | PURCHASE | Alzinova AB | 1,345,000 | 2.40 SEK | |
| 25 Feb 2026 | PURCHASE | Alzinova AB | 1,467,239 | 2.40 SEK | |
| 20 May 2025 | LENDING | Alzinova AB | 1,475,000 | 1.55 SEK | |
| 22 May 2025 | LENDING | Alzinova AB | 1,475,000 | 1.55 SEK | |
| 09 May 2025 | PURCHASE | Alzinova AB | 2,926,483 | 2.00 SEK | first after silence |
| 05 Nov 2018 | OTHER | Oasmia Pharmaceutical AB | 857,142 | 7.70 SEK | |
| 25 Sept 2018 | SALE | Oasmia Pharmaceutical AB | 36,751 | 12.00 SEK | |
| 27 Sept 2018 | PURCHASE | Oasmia Pharmaceutical AB | 9,500 | 14.40 SEK | |
| 06 Sept 2018 | PURCHASE | Oasmia Pharmaceutical AB | 36,751 | 6.80 SEK |
1 purchase reported after at least 12 months of silence — most recent on 09 May 2025.